SEC Form 4 · accession 0001645627-17-000016
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Feb 28, 2017
Accepted (ET)
Mar 20, 2017 · 3:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2017 | P | 1,000 | $0.0181 | A | 19,773,649 | D | |
| Common Stock | Mar 2, 2017 | P | 1,000 | $0.0148 | A | 19,774,649 | D | |
| Common Stock | Mar 2, 2017 | P | 1,000 | $0.0149 | A | 19,775,649 | D | |
| Common Stock | Mar 2, 2017 | P | 1,000 | $0.0163 | A | 19,776,649 | D | |
| Common Stock | Mar 2, 2017 | P | 2,000 | $0.0163 | A | 19,778,649 | D | |
| Common Stock | Mar 2, 2017 | P | 1,000 | $0.0171 | A | 19,779,649 | D | |
| Common Stock | Mar 2, 2017 | P | 2,000 | $0.017 | A | 19,781,649 | D | |
| Common Stock | Mar 3, 2017 | P | 1,000 | $0.0158 | A | 19,782,649 | D | |
| Common Stock | Mar 3, 2017 | P | 1,000 | $0.0156 | A | 19,783,649 | D | |
| Common Stock | Mar 3, 2017 | P | 1,000 | $0.0155 | A | 19,784,649 | D | |
| Common Stock | Mar 3, 2017 | P | 1,000 | $0.0155 | A | 19,785,649 | D | |
| Common Stock | Mar 3, 2017 | P | 1,000 | $0.0154 | A | 19,786,649 | D | |
| Common Stock | Mar 7, 2017 | P | 1,000 | $0.0139 | A | 19,787,649 | D | |
| Common Stock | Mar 7, 2017 | P | 200 | $0.0144 | A | 19,787,849 | D | |
| Common Stock | Mar 7, 2017 | P | 200 | $0.0144 | A | 19,788,049 | D | |
| Common Stock | Mar 7, 2017 | P | 200 | $0.0145 | A | 19,788,249 | D | |
| Common Stock | Mar 8, 2017 | P | 200 | $0.0139 | A | 19,788,449 | D |
Table II — derivative securities
No Table II lines on this filing.